A brief history of FRAX

Management of Patients With High Baseline Hip Fracture Risk by FRAX Reduces Hip Fractures-A Post Hoc Analysis of the SCOOP Study

(2018) Eugene McCloskey et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Comparison of Methods for Improving Fracture Risk Assessment in Diabetes: The Manitoba BMD Registry

(2018) William D Leslie et al.   JOURNAL OF BONE AND MINERAL RESEARCH

The Cost-Effectiveness of Screening in the Community to Reduce Osteoporotic Fractures in Older Women in the UK: Economic Evaluation of the SCOOP Study

(2018) David A Turner et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Screening in the community to reduce fractures in older women (SCOOP): a randomised controlled trial

(2018) Lee Shepstone et al.   LANCET

Correcting the Record on a Fracture Risk Assessment Tool

(2018) Laragh Gollogly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Risk-equivalent T-score adjustment for using lumbar spine trabecular bone score (TBS): the Manitoba BMD registry

(2018) W. D. Leslie et al.   OSTEOPOROSIS INTERNATIONAL

Epidemiology of hip fracture in Belarus: development of a country-specific FRAX model and its comparison to neighboring country models

(2018) H. Ramanau et al.   Archives of Osteoporosis

The Effect of Abaloparatide-SC on Fracture Risk Is Independent of Baseline FRAX Fracture Probability: A Post Hoc Analysis of the ACTIVE Study

(2017) Eugene V McCloskey et al.   JOURNAL OF BONE AND MINERAL RESEARCH

FRAX-based intervention and assessment thresholds in seven Latin American countries

(2017) P. Clark et al.   OSTEOPOROSIS INTERNATIONAL

FRAX- vs. T-score-based intervention thresholds for osteoporosis

(2017) H. Johansson et al.   OSTEOPOROSIS INTERNATIONAL

Epidemiology of fractures in Armenia: development of a country-specific FRAX model and comparison to its surrogate

(2017) O. Lesnyak et al.   Archives of Osteoporosis

Evaluation of clinical risk factors for osteoporosis and applicability of the FRAX tool in Joinville City, Southern Brazil

(2017) Dalisbor Marcelo Weber Silva et al.   Archives of Osteoporosis

Epidemiology of hip fracture and the development of FRAX in Ukraine

(2017) VV Povoroznyuk et al.   Archives of Osteoporosis

UK clinical guideline for the prevention and treatment of osteoporosis

(2017) J. Compston et al.   Archives of Osteoporosis

Clarifying WHO’s position on the FRAX® tool for fracture prediction

(2016) Nathan Ford et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Adjusting Hip Fracture Probability in Men and Women Using Hip Axis Length: the Manitoba Bone Density Database

(2016) William D. Leslie et al.   JOURNAL OF CLINICAL DENSITOMETRY

Evidence, expertise, and facts in a “post-truth” society

(2016) Tracey Brown   BMJ-British Medical Journal

Evidence, expertise, and facts in a “post-truth” society

(2016) Tracey Brown   BMJ-British Medical Journal

A systematic review of intervention thresholds based on FRAX

(2016) John A. Kanis et al.   Archives of Osteoporosis

The accuracy of osteoporotic fracture risk prediction tools: a systematic review and meta-analysis

(2015) Andréa Marques et al.   ANNALS OF THE RHEUMATIC DISEASES

Adjusting Fracture Probability by Trabecular Bone Score

(2015) Eugene V. McCloskey et al.   CALCIFIED TISSUE INTERNATIONAL

Intervention Thresholds and the Diagnosis of Osteoporosis

(2015) John A Kanis et al.   JOURNAL OF BONE AND MINERAL RESEARCH

A Meta-Analysis of Trabecular Bone Score in Fracture Risk Prediction and Its Relationship to FRAX

(2015) Eugene V McCloskey et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Osteoporosis: the emperor has no clothes

(2015) T. L. N. Järvinen et al.   JOURNAL OF INTERNAL MEDICINE

Burden of high fracture probability worldwide: secular increases 2010–2040

(2015) A. Odén et al.   OSTEOPOROSIS INTERNATIONAL

Is the Swedish FRAX model appropriate for Swedish immigrants?

(2015) H. Johansson et al.   OSTEOPOROSIS INTERNATIONAL

Overdiagnosis of osteoporosis: fact or fallacy?

(2015) J. Compston   OSTEOPOROSIS INTERNATIONAL

Predictive ability of heel quantitative ultrasound for incident fractures: an individual-level meta-analysis

(2015) E. V. McCloskey et al.   OSTEOPOROSIS INTERNATIONAL

Efficacy of weekly teriparatide does not vary by baseline fracture probability calculated using FRAX

(2015) N. C. Harvey et al.   OSTEOPOROSIS INTERNATIONAL

Systematic review and meta-analysis of the performance of clinical risk assessment instruments for screening for osteoporosis or low bone density

(2015) S. Nayak et al.   OSTEOPOROSIS INTERNATIONAL

Overdiagnosis of bone fragility in the quest to prevent hip fracture

(2015) T. L. Jarvinen et al.   BMJ-British Medical Journal

Overdiagnosis of bone fragility in the quest to prevent hip fracture

(2015) T. L. Jarvinen et al.   BMJ-British Medical Journal

Incidence of hip fracture in Brazil and the development of a FRAX model

(2015) C. A. F. Zerbini et al.   Archives of Osteoporosis

Evaluation of the FRAX Model for Hip Fracture Predictions in the Population-based Kuopio Osteoporosis Risk Factor and Prevention Study (OSTPRE)

(2014) Reijo Sund et al.   CALCIFIED TISSUE INTERNATIONAL

Impact of Femoral Neck and Lumbar Spine BMD Discordances on FRAX Probabilities in Women: A Meta-analysis of International Cohorts

(2014) H. Johansson et al.   CALCIFIED TISSUE INTERNATIONAL

The incidence of a first major osteoporotic fracture in Iceland and implications for FRAX

(2014) K. Siggeirsdottir et al.   OSTEOPOROSIS INTERNATIONAL

The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group

(2014) E. S. Siris et al.   OSTEOPOROSIS INTERNATIONAL

Lumbar spine texture enhances 10-year fracture probability assessment

(2014) W. D. Leslie et al.   OSTEOPOROSIS INTERNATIONAL

Incidence of Hip Fracture in Romania and the Development of a Romanian FRAX Model

(2013) Daniel Grigorie et al.   CALCIFIED TISSUE INTERNATIONAL

Incidence of Hip Fracture in Barranquilla, Colombia, and the Development of a Colombian FRAX Model

(2013) J. J. Jaller-Raad et al.   CALCIFIED TISSUE INTERNATIONAL

Conflicts at the heart of the FRAX tool

(2013) T. L. N. Jarvinen et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Major Osteoporotic to Hip Fracture Ratios in Canadian Men and Women With Swedish Comparisons: A Population-Based Analysis

(2013) Anna Lam et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Mild morphometric vertebral fractures predict vertebral fractures but not non-vertebral fractures

(2013) H. Johansson et al.   OSTEOPOROSIS INTERNATIONAL

Comparison between various fracture risk assessment tools

(2013) W. D. Leslie et al.   OSTEOPOROSIS INTERNATIONAL

Development and application of FRAX in the management of osteoporosis in Ireland

(2013) B McGowan et al.   Archives of Osteoporosis

FRAX® tool, the WHO algorithm to predict osteoporotic fractures: the first analysis of its discriminative and predictive ability in the Spanish FRIDEX cohort

(2012) Rafael Azagra et al.   BMC MUSCULOSKELETAL DISORDERS

Hip Fracture Incidence from 1981 to 2009 in the Czech Republic as a Basis of the Country-Specific FRAX Model

(2012) Jan J. Stepan et al.   CALCIFIED TISSUE INTERNATIONAL

Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX

(2012) Eugene V McCloskey et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Effect of alendronate for reducing fracture by FRAX score and femoral neck bone mineral density: The fracture intervention trial

(2012) Meghan G Donaldson et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Type 2 diabetes and bone

(2012) William D Leslie et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Intervention thresholds for denosumab in the UK using a FRAX®-based cost-effectiveness analysis

(2012) O. Ström et al.   OSTEOPOROSIS INTERNATIONAL

Updated fracture incidence rates for the Italian version of FRAX®

(2012) P. Piscitelli et al.   OSTEOPOROSIS INTERNATIONAL

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

(2012) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

The impact of a FRAX-based intervention threshold in Turkey: the FRAX-TURK study

(2012) Sansin Tuzun et al.   Archives of Osteoporosis

Epidemiology of fracture in the Russian Federation and the development of a FRAX model

(2012) Olga Lesnyak et al.   Archives of Osteoporosis

FRAX® with and without Bone Mineral Density

(2011) John A. Kanis et al.   CALCIFIED TISSUE INTERNATIONAL

WHO absolute fracture risk models (FRAX): Do clinical risk factors improve fracture prediction in older women without osteoporosis?

(2011) Teresa A Hillier et al.   JOURNAL OF BONE AND MINERAL RESEARCH

FRAX underestimates fracture risk in patients with diabetes

(2011) Lora M Giangregorio et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Joint Official Positions of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®

(2011) Didier B. Hans et al.   JOURNAL OF CLINICAL DENSITOMETRY

Official Positions for FRAX® Clinical Regarding Falls and Frailty: Can Falls and Frailty be Used in FRAX®?

(2011) Tahir Masud et al.   JOURNAL OF CLINICAL DENSITOMETRY

Comment on: cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis

(2011) B. Jönsson et al.   OSTEOPOROSIS INTERNATIONAL

Incidence of hip fracture and prevalence of osteoporosis in Turkey: the FRACTURK study

(2011) S. Tuzun et al.   OSTEOPOROSIS INTERNATIONAL

Calibration of FRAX ® 3.1 to the Dutch population with data on the epidemiology of hip fractures

(2011) A. Lalmohamed et al.   OSTEOPOROSIS INTERNATIONAL

Pitfalls in the external validation of FRAX

(2011) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

Erratum to: A meta-analysis of the effect of strontium ranelate on the risk of vertebral and non-vertebral fracture in postmenopausal osteoporosis and the interaction with FRAX®

(2011) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

Guidance for the adjustment of FRAX according to the dose of glucocorticoids

(2011) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

Interpretation and use of FRAX in clinical practice

(2011) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

Ten-year probability of osteoporotic fracture in 2012 Polish women assessed by FRAX and nomogram by Nguyen et al.—Conformity between methods and their clinical utility

(2010) W. Pluskiewicz et al.   BONE

FRAX® and its applications in health economics—Cost-effectiveness and intervention thresholds using bazedoxifene in a Swedish setting as an example

(2010) O. Ström et al.   BONE

A meta-analysis of the efficacy of raloxifene on all clinical and vertebral fractures and its dependency on FRAX®

(2010) John A. Kanis et al.   BONE

The diagnosis of osteoporosis

(2010) John A. Kanis et al.   JOURNAL OF BONE AND MINERAL RESEARCH

The FRAX tool in French women: How well does it describe the real incidence of fracture in the OFELY cohort

(2010) Elisabeth Sornay-Rendu et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Fracture risk prediction using BMD and clinical risk factors in early postmenopausal women: Sensitivity of the WHO FRAX tool

(2010) Florence A Trémollieres et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Evaluation of the FRAX and Garvan fracture risk calculators in older women

(2010) Mark J Bolland et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Hip fracture risk in older US adults by treatment eligibility status based on new National Osteoporosis Foundation guidance

(2010) A. C. Looker et al.   OSTEOPOROSIS INTERNATIONAL

Evaluation of FRAX to characterise fracture risk in Poland

(2010) E. Czerwinski et al.   OSTEOPOROSIS INTERNATIONAL

A FRAX® model for the assessment of fracture probability in Belgium

(2010) H. Johansson et al.   OSTEOPOROSIS INTERNATIONAL

Spine–hip discordance and fracture risk assessment: a physician-friendly FRAX enhancement

(2010) W. D. Leslie et al.   OSTEOPOROSIS INTERNATIONAL

Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment

(2010) W. D. Leslie et al.   OSTEOPOROSIS INTERNATIONAL

Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis

(2010) B. Jönsson et al.   OSTEOPOROSIS INTERNATIONAL

A Comparison of Prediction Models for Fractures in Older Women

(2009) Kristine E. Ensrud   ARCHIVES OF INTERNAL MEDICINE

Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX®

(2009) John A. Kanis et al.   BONE

FRAX and Risk of Vertebral Fractures: The Fracture Intervention Trial

(2009) Meghan G Donaldson et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK

(2009) J. Compston et al.   MATURITAS

FRAX® assessment of osteoporotic fracture probability in Switzerland

(2009) K. Lippuner et al.   OSTEOPOROSIS INTERNATIONAL

Ten-year fracture probability in Hong Kong Southern Chinese according to age and BMD femoral neck T-scores

(2009) S. W. Y. Tsang et al.   OSTEOPOROSIS INTERNATIONAL

Updated fracture incidence rates for the US version of FRAX®

(2009) B. Ettinger et al.   OSTEOPOROSIS INTERNATIONAL

Prognosis of fracture: evaluation of predictive accuracy of the FRAX™ algorithm and Garvan nomogram

(2009) S. K. Sandhu et al.   OSTEOPOROSIS INTERNATIONAL

The potential impact of new National Osteoporosis Foundation guidance on treatment patterns

(2009) B. Dawson-Hughes et al.   OSTEOPOROSIS INTERNATIONAL

Vertebral Fracture Status and the World Health Organization Risk Factors for Predicting Osteoporotic Fracture Risk*

(2008) Peiqi Chen et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX™)

(2008) S. Fujiwara et al.   OSTEOPOROSIS INTERNATIONAL

Incorporating adherence into health economic modelling of osteoporosis

(2008) O. Ström et al.   OSTEOPOROSIS INTERNATIONAL

Ten-year fracture probability identifies women who will benefit from clodronate therapy—additional results from a double-blind, placebo-controlled randomised study

(2008) E. V. McCloskey et al.   OSTEOPOROSIS INTERNATIONAL

Remaining lifetime and absolute 10-year probabilities of osteoporotic fracture in Swiss men and women

(2008) K. Lippuner et al.   OSTEOPOROSIS INTERNATIONAL

Cost-effective osteoporosis treatment thresholds: the United States perspective

(2008) A. N. A. Tosteson et al.   OSTEOPOROSIS INTERNATIONAL

Case finding for the management of osteoporosis with FRAX®—assessment and intervention thresholds for the UK

(2008) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

The cost-effectiveness of alendronate in the management of osteoporosis

(2007) John A. Kanis et al.   BONE

A reference standard for the description of osteoporosis

(2007) John A. Kanis et al.   BONE